Injection Clinical Trials

46 recruitingLast updated: May 13, 2026

There are 46 actively recruiting injection clinical trials across 18 countries. Studies span Not Applicable, Phase 2, Phase 4, Early Phase 1, Phase 1, Phase 3. Top locations include Nanjing, Jiangsu, China, Taipei, Taiwan, Atlanta, Georgia, United States. Updated daily from ClinicalTrials.gov.


Injection Trials at a Glance

46 actively recruiting trials for injection are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in Nanjing, Taipei, and Atlanta. Lead sponsors running injection studies include Afyonkarahisar Health Sciences University, Andalas University, and Abramson Cancer Center at Penn Medicine.

Browse injection trials by phase

Treatments under study

About Injection Clinical Trials

Looking for clinical trials for Injection? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Injection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Injection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 46 trials

Recruiting
Not Applicable

Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine

Pain From onabotulinumtoxinA Injections
Association of Migraine Disorders18 enrolled1 locationNCT07571889
Recruiting
Phase 4

Arthrosamid vs. Steroid for the Management of Knee Osteoarthritis

Osteo Arthritis KneeOsteoarthritisIntraarticular Injection
Cappagh National Orthopaedic Hospital200 enrolled1 locationNCT07489521
Recruiting
Phase 4

Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use

Immune DysregulationHIVSystemic Inflammation+1 more
University of Alabama at Birmingham100 enrolled1 locationNCT06829238
Recruiting
Not Applicable

Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis

ChildrenLocal InjectionDysfunctional Voiding+2 more
Tanta University64 enrolled1 locationNCT07523477
Recruiting
Phase 2

Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures

Pain ManagementMandible FractureCorticosteroid Injection+1 more
Nishtar Medical University72 enrolled1 locationNCT07208799
Recruiting
Phase 4

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

HIVSubstance Use Disorder (SUD)Injection Drug Use
Massachusetts General Hospital100 enrolled2 locationsNCT07199335
Recruiting
Not Applicable

Real-Time Monitoring of the Injection Pressure During the Peripheral Nerve Block

No ConditionReal-time Monitoring of the Injection Pressure During Ultrasound-guided Axillary Block
Ente Ospedaliero Cantonale, Bellinzona34 enrolled1 locationNCT07302997
Recruiting
Phase 2

Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and Without Intra-articular Platelet-Rich Plasma Injection.

ACL reconstructionPRPIntraarticular Injection
Lahore General Hospital60 enrolled1 locationNCT07470359
Recruiting
Not Applicable

Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome

carpal tunnel syndromeSurgeryMusculoskeletal Diseases+2 more
Afyonkarahisar Health Sciences University60 enrolled1 locationNCT06243848
Recruiting
Not Applicable

The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery

Pain ManagementVideo-assisted Thoracoscopic Surgery (VATS)Liposomal Bupivacaine+1 more
Beijing Tiantan Hospital100 enrolled1 locationNCT07432711
Recruiting
Phase 4

Implementing Low-Barrier HCV Treatment in a Jail Setting

Implementation ScienceIncarcerationInjection Drug Use+1 more
Lifespan40 enrolled1 locationNCT06953479
Recruiting
Phase 2

Effect of TXA on Reducing Bruising After Filler Injection

Hyaluronic AcidTranexamic AcidFacial Filler Injections
University of Wisconsin, Madison40 enrolled1 locationNCT06665594
Recruiting
Early Phase 1

Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.

Colorectal, CancerDC-CIK TreatmentRegorafenib+2 more
JIANG LONGWEI14 enrolled1 locationNCT07343791
Recruiting
Not Applicable

The Effects of Intra-articular and Peri-articular Platelet-rich Plasma (PRP) Injections ın Chronic Knee Osteoarthritis

gonarthrosisUltrasonographyPlatelet Rich Plasma Injection
Ankara City Hospital Bilkent42 enrolled1 locationNCT07339137
Recruiting

Levothyroxine Treatment and IVF Outcomes in Women With Subclinical Hypothyroidism: A Target Trial Emulation

InfertilitySubclinical HypothyroidismIn Vitro Fertilization (IVF)+3 more
Mỹ Đức Hospital900 enrolled2 locationsNCT07257250
Recruiting
Phase 2

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

BevacizumabHepatecellular CarcinomaRALOX-HAIC(Hepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin+3 more
Nanfang Hospital, Southern Medical University38 enrolled1 locationNCT07327788
Recruiting
Not Applicable

The Value of Standardized Respiratory Rate Monitoring Exercises During Rheumatological Injection Procedures

Pain ManagementRheumatological InjectionRespiratory Monitoring
Centre Hospitalier Metropole Savoie136 enrolled1 locationNCT07172984
Recruiting
Not Applicable

Is Adding Extracorporeal Shock Wave Therapy to Physiotherapy and Corticosteroid Injection Beneficial for Frozen Shoulder

RehabilitationPhysical TherapyCorticosteroid Injection+2 more
Shin Kong Wu Ho-Su Memorial Hospital94 enrolled1 locationNCT06491745
Recruiting
Not Applicable

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans120 enrolled5 locationsNCT06834113
Recruiting
Early Phase 1

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer

Endometrial CancerNear Infrared Fluorescence ImagingCYTALUX (Pafolacianine) Injection+1 more
Abramson Cancer Center at Penn Medicine10 enrolled2 locationsNCT07278986